Praxis Precision Medicines (PRAX.US) Latest Stock News - Major News Analysis

Quote List Quote List

Event Tracking

Dec29

Analyst Raises Praxis Precision Medicines Target Price to $534

16:27

Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation; Pre-Market Stock Up Over 11%

13:35

Praxis Precision Medicines' Drug Ulixacaltamide Receives FDA Breakthrough Therapy Designation

13:16

BTIG analyst reiterates Praxis Precision Medicines stock buy rating

11:21

Dec23

Praxis Precision Medicines Obtains FDA Approval to Redesign elsunersen's EMBRAVE3 Trial

14:28

Dec20

Praxis Precision Reorganizes EMBRAVE3 Trial, Shares Surge

10:38

Schedules & Filings

Schedules

Filings

Nov5

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -73.93 M, EPS -3.3641

Aug4

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -71.13 M, EPS -3.3121

May2

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -69.3 M, EPS -3.291

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change